Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp404 | Osteoporosis: treatment | ECTS2013

Sequential therapy after PTH 1–84 treatment: comparison among bisphosphonates and strontium ranelate

Pastore Renato , Mentuccia Daniela , Pasqualetti Patrizio , Frajese Gaetano

Introduction: Evidence in literature shows how is useful to use antiresorptive drugs such as bisphosphonates, in severe osteoporosi severe after PTH (1–34 or 1–84) treatment.Methods: This study was divided into two parts: the first one analyzed BMD changes by DXA at the lumbar and femoral and serum osteocalcin and β-CTX, monitoring their performance after 6, 12 and 18 months in 71 women with severe postmenopausal osteoporosis, treated for ...

ba0003pp334 | Osteoporosis: treatment | ECTS2014

Comparison of efficacy teriparatide between denosumab and on hip BMD in women with severe post-menopausal osteoporosis

Pastore Renato , Mentuccia Daniela , Pasqualetti Patrizio , Frontoni Simona

Introduction: Teriparatide is a potent anabolic drug that has demonstrated efficacy on fracture risk reduction in women with severe postmenopausal osteoporosis. Denosumab, designed to inhibit RANKL (RANK ligand), is a fully human MAB for the treatment of osteoporosis. BMD changes, measured by DXA, is an established tool for monitoring the effects of anti-osteoporotic therapy. Our purpose is to compare teriparatide vs denosumab efficacy on hip BMD variations, in postmenopausal ...

ba0003pp346 | Osteoporosis: treatment | ECTS2014

Efficacy of Denosumab on bone metabolism after a 12-month treatment, in women with severe post-menopausal osteoporosis

Pastore Renato , Pasqualetti Patrizio , Chioma Laura , Vancieri Giuseppe , Frontoni Simona

Introduction: Denosumab, a fully human monoclonal antibody to RANK ligand, effectively reduces bone resorption by inhibiting RANK-L binding to RANK. We aimed to evaluate the efficacy of denosumab in post-menopausal women, by monitoring the evolution of different parameters of bone health: T-score, morphometry, osteocalcin and β-Ctx.Methods: A 34 women with severe postmenopausal osteoporosis, characterized by multiple vertebral fractures wer...

ba0001pp44 | Bone biomechanics and quality | ECTS2013

2-Oxoglutaric acid protects against side effects of maximal therapeutic doses of dexamethasone in piglets skeleton

Dobrowolski Piotr , Tomaszewska Ewa , Kurlak Paulina , Pierzynowski Stefan

Synthetic glucocorticoids such as dexamethasone (Dex) are widely used for treatment of premature infants with chronic lung disease or respiratory distress syndrome or in allergic conditions such as asthma. Adverse effect of these treatments is glucocorticoids-induced osteoporosis. On the other hand there are functional foods, for instance 2-oxoglutaric acid (2-Ox) a precursor of hydroxyproline the prevailing amino acid in bone collagen, which reduce the risk of osteoporosis. T...

ba0001pp259 | Chondrocytes and cartilage | ECTS2013

The influence of 2-oxoglutaric acid on articular cartilage of gastrectomised rats

Dobrowolski Piotr , Tomaszewska Ewa , Kurlak Paulina , Pierzynowski Stefan

Surgical removal of the stomach (gastrectomy, Gx) leads to osteopenia in animals and in humans. In the rat, Gx causes loss of calvaria and trabecular bone, which can be reduced by 2-oxoglutaric acid (2-Ox), a precursor of hydroxyproline the most abundant amino acid in bone collagen. The purpose of this study was to investigate the effects (if any) of Gx on articular cartilage and if dietary 2-Ox can protects against eventual adverse effects of Gx. Twenty female Sprague–Da...

ba0003cc2 | (1) | ECTS2014

Hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; Long-term clinical outcome and phenotypic variability.

Rafaelsen Silje , Johansson Stefan , Raeder Helge , Bjerknes Robert

Background: Hyperphosphatemic Familial Tumoral Calcinosis (HFTC) and Hyperphosphatemic Hyperostosis Syndrome (HHS) are two phenotypes of a disease associated with autosomal recessive mutations in FGF23, GALNT3 and KL, leading to reduced levels and clinical effects of fibroblast growth factor 23 (FGF23). We describe a consanguineous family with two affected individuals with HFTC and HHS caused by a novel homozygous mutation in GALNT3. We also...

ba0001pp331 | Osteoporosis: evaluation and imaging | ECTS2013

May we screen with FRAX clinical factors?

Barbu Carmen Gabriela , Poiana Catalina , Ionita Dariana , Gascan Magda , Stefan Cristina , Stefanopol Aurelia , Fica Simona

Aim: The aim of the study was to evaluate the usefulness of the fracture risk evaluated through the FRAX® model based only on the clinical risk factors as a screening tool for identify the target population for treatment in osteoporosis.Materials and methods: Two hundred and seventy-six postmenopausal women treatment naive referred to two different endocrinology departments for osteoporosis between 2009 and 2011 were evaluated. The FRAX® model ...

ba0005oc1.6 | Clinical trials and osteoporosis treatment | ECTS2016

Standard QCT shows substantial underestimation of treatment effects on bone mineral density: impact of spatial resolution

Reinhold Stefan , Damm Timo , Pena Jaime , Barkmann Reinhard , Gluer Claus-C

Quantitative Computed Tomography (QCT) can be performed with different protocols. We investigated whether selection of spatial resolution, reconstruction method, and scanner type have an impact on measured treatment effects for different bone compartments.Methods: In a multi-center study, a group of 50 men, age 55.1 (range 25–78) undergoing 18 months of either osteoanabolic (n=25) or antiresorptive treatment (n=25) were scanned wit...

ba0005p250 | Genetics and Epigenetics | ECTS2016

Advancing maternal age at childbirth is associated with less favourable trabecular bone mineral density and tibial cortical bone geometry in young adult male offspring

Verroken Charlotte , Zmierczak Hans , Goemaere Stefan , Kaufman Jean-Marc , Lapauw Bruno

Background: Advancing maternal age at childbirth has been associated with a higher risk of pregnancy complications and with adverse short-term and long-term offspring health outcomes, but little is known about the effects of increasing maternal age on offspring bone acquisition.Objective: To investigate associations of maternal age at childbirth with offspring bone parameters in healthy men at the age of peak bone mass.Methods: We ...

ba0005p261 | Muscle, physical activity and bone | ECTS2016

Bone and muscle metabolism in lung transplant recipients

Foger-Samwald Ursula , Petrikic Aleksandra , Gruther Wolfgang , Ebenbichler Gerold , Kudlacek Stefan , Pietschmann Peter

Although it is well established, that quality of life improves in patients after lung transplantation (LTx), severe musculoskeletal complications may develop. The aim of this study was to evaluate differences in the muscle markers Myostatin and Follistatin and the bone markers Dickkopf-1 (DKK1), Sclerostin (SOST) and Periostin between LuTx recipients and healthy controls. From 38 LTx patients blood samples were taken when discharged from hospital (LTx1) and 6-9 months after di...